Lv3
342 积分 2024-12-18 加入
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
19小时前
已完结
Antisense and siRNA as agonists of Toll-like receptors
17天前
已完结
RNAi-based drug design: considerations and future directions
17天前
已完结
Growth differentiation factor 15 (GDF-15) in kidney diseases
2个月前
已完结
Growth differentiation factor 15 (GDF-15) in kidney diseases
2个月前
已关闭
Growth differentiation factor 15 (GDF-15) in kidney diseases
2个月前
已关闭
Activin E upregulates uncoupling protein 1 and fibroblast growth factor 21 in brown adipocytes
2个月前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
2个月前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
2个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
2个月前
已完结
皖公网安备34019202002308
